The global transition from incandescent to LED lighting, driven by energy-saving mandates like the 2016 EU ban, is facing new scrutiny over its biological impact. While LEDs use 90% less power, researchers are investigating whether the lack of infrared light contributes to metabolic disorders.
The 2016 EU ban and the rise of the 90% energy-saving bulb
The transition from traditional tungsten filaments to LED technology was largely motivated by a global push to reduce carbon emissions. Following a 2009 EU directive, the manufacture and sale of new incandescent bulbs were phased out, culminating in a full ban in 2016. As the report notes, while these older bulbs can still be used in limited circumstances, the vast majority of homes, schools, and hospitals have transitioned to LED technology, which consumes roughly 90% less power than its predecessor.
This efficiency comes with a fundamental change in light quality. Incandescent bulbs produce light by heating a thin tungsten filament, a process that is highly inefficient as roughly 90% of the energy is wasted as heat. In contrast, LEDs use light-emitting diodes to produce light, a method that prioritizes energy conservation but shifts the spectral output toward the blue end of the spectrum.
Glen Jeffery’s warning on mitochondrial decline
The shift toward blue-dominant lighting may be creating a biological deficit in the modern built environment. LEDs primarily emit short-wavelength blue light, ranging from approximately 400 to 500 nanometres, which is significantly harsher than the warm light of incandescent bulbs. Glen Jeffery, a professor at University College London, suggests that because we spend most of our time indoors with LEDs, we are receiving far less long-wave light than our ancestors did.
According to the findings reported by the source, this lack of deep red or infrared light could have cumulative physiological effects. Scientists suspect that the absence of these wavelengths may impair mitochondrial function within human cells.. This cellular decline is being linked to a variety of serious health outcomes, including obesity, skin aging,and even type 2 diabetes.
The Maastricht University findings on glucose stability
Recent clinical observations have begun to provide empirical weight to these metabolic concerns. A 2024 study published in the Journal of Biophotonics by Jeffery's team demonstrated that a brief 15-minute burst of red light could significantly lower blood-sugar levels in participants following a large glucose intake. This suggests that specific wavelengths play a direct role in regulating energy metabolism.
Further evidence emerged from a December study conducted by Maastricht University in the Netherlands. researchers observed 13 participants with type 2 diabetes who spent alternating periods in an LED-lit office and under natural light. The study found that participants' glucose levels remained more stable when they were exposed to natural light, highlighting the potential metabolic instability caused by artificial LED environments.
The unanswered question of "circadian-friendly" marketing
As the debate intensifies, the relationship between light and the human body remains complex and somewhat unsettled. Russell Foster, a professor of circadian neuroscience at the University of Oxford, notes that the science is not as simple as labeling all blue light as "bad" and all red light as "good." He emphasizes that the intensity, duration, and timing of light exposure are all critical variables that dictate how our internal clocks respond.
This complexity leaves several questions regarding the current market response. while some companies are now marketing "circadian-friendly" LEDs that incorporate warmer tones, it remains unverified how these products compare to the full spectrum of natural light.. The report highlights that as research continues, the industry must grapple with whether current lighting standards in schools and workplaces are sufficient for long-term human health.
Comments 0